Dopamine Agonists in Sleep Disorders
Introduction to Pramipexole
- Pramipexole is a dopamine agonist that may cause cognitive impairment as a recognized side effect, according to the American Academy of Sleep Medicine guidelines 1
Patient Factors Influencing Cognitive Effects
- Older patients (>70 years) with pre-existing cognitive impairment or dementia with Lewy bodies may experience worsened symptoms when taking pramipexole, as noted by the American Academy of Sleep Medicine guidelines 1
- Patients with dementia with Lewy bodies (DLB) may have exacerbated symptoms when taking dopamine agonists like pramipexole, as reported by the American Academy of Sleep Medicine 1
Prescribing Considerations
- The American Geriatrics Society recommends starting with low doses of pramipexole (0.125 mg) and titrating slowly to minimize cognitive side effects 2
- Evening dosing of pramipexole may help minimize daytime concentration problems, as suggested by the American Academy of Sleep Medicine 1
- Renal function monitoring is necessary, as clearance correlates with renal function, and dosage adjustment may be needed in patients with renal insufficiency 3, 1
Alternative Treatments
- Clonazepam and melatonin have stronger evidence for efficacy in RBD treatment with potentially fewer cognitive side effects than pramipexole, according to the American Academy of Sleep Medicine guidelines 3, 1
- Gabapentin or gabapentin enacarbil are strongly recommended as first-line treatments for RLS, while pramipexole is an alternative option 4
Common Side Effects
- Orthostatic hypotension, nausea, vomiting, excessive daytime somnolence, impulse-control disorders, hallucinations, and delusions are common side effects of pramipexole 3
- Patients should be informed about the risk of impulse control disorders when taking pramipexole 3
Treatment Guidelines
- The American Academy of Sleep Medicine conditionally suggests pramipexole for isolated RBD, particularly in patients with elevated periodic limb movements on polysomnography 3
- Starting dose for RBD treatment is 0.125 mg at bedtime, which can be titrated up to 2.0 mg nightly 3
- Mean nightly doses in studies for RBD treatment range from 0.78-0.89 mg 1
- Pramipexole has a lower prevalence of augmentation compared to levodopa in RLS treatment 3